(Q84241823)

English

Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx

scientific article published on 15 May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

membrane protein

1 reference

based on heuristic

inferred from title

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kenji Noda

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Satoru Kodama

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Shingo Umemoto

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Nobuyuki Abe

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Takashi Hirano

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Masashi Suzuki

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

15 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

5068-5074

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Respiratory infections caused by non-typeable Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Developing a nontypeable Haemophilus influenzae (NTHi) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Mucosal immunity and tolerance: relevance to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Strategies for designing and optimizing new generation vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

The Role of Mucosal Immunity in Prevention of HIV Transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

NALT- versus Peyer's-patch-mediated mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

The NKT cell system: bridging innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

NKT cell ligand alpha-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Harnessing invariant NKT cells in vaccination strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

CD1-dependent dendritic cell instruction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

based on heuristic

inferred from DOI database lookup

CD1d-restricted help to B cells by human invariant natural killer T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Invariant NKT cells sustain specific B cell responses and memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

NK T cells provide lipid antigen-specific cognate help for B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Effects of the lpr/lpr mutation on T and B cell populations in the lamina propria of the small intestine, a mucosal effector site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Polarized Th2 cytokine expression by both mucosal gamma delta and alpha beta T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.05.005

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.05.005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478344%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84241823&oldid=1790197341"